NR3C1 and Alzheimer disease: Epigenetic modifications, such as DNA methylation in the NR3C1, have also been associated with altered hypothalamic–pituitary–adrenal axis function [53,54] and increased stress vulnerability [55], both of which may heighten the risk of AD.